Report Detail

Pharma & Healthcare Global Frovatriptan Market Research Report 2021

  • RnM4300828
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Frovatriptan Market Overview

  • 1.1 Product Overview and Scope of Frovatriptan
  • 1.2 Frovatriptan Segment by Type
    • 1.2.1 Global Frovatriptan Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Hospital
    • 1.2.3 Drug Store
  • 1.3 Frovatriptan Segment by Application
    • 1.3.1 Frovatriptan Sales Comparison by Application: (2021-2027)
    • 1.3.2 Menstrual Migraines
    • 1.3.3 Migraine with Aura
    • 1.3.4 Migraine without Aura
  • 1.4 Global Frovatriptan Market Size Estimates and Forecasts
    • 1.4.1 Global Frovatriptan Revenue 2016-2027
    • 1.4.2 Global Frovatriptan Sales 2016-2027
    • 1.4.3 Frovatriptan Market Size by Region: 2016 Versus 2021 Versus 2027

2 Frovatriptan Market Competition by Manufacturers

  • 2.1 Global Frovatriptan Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Frovatriptan Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Frovatriptan Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Frovatriptan Manufacturing Sites, Area Served, Product Type
  • 2.5 Frovatriptan Market Competitive Situation and Trends
    • 2.5.1 Frovatriptan Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Frovatriptan Players Market Share by Revenue
    • 2.5.3 Global Frovatriptan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Frovatriptan Retrospective Market Scenario by Region

  • 3.1 Global Frovatriptan Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Frovatriptan Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Frovatriptan Market Facts & Figures by Country
    • 3.3.1 North America Frovatriptan Sales by Country
    • 3.3.2 North America Frovatriptan Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Frovatriptan Market Facts & Figures by Country
    • 3.4.1 Europe Frovatriptan Sales by Country
    • 3.4.2 Europe Frovatriptan Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Frovatriptan Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Frovatriptan Sales by Region
    • 3.5.2 Asia Pacific Frovatriptan Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Frovatriptan Market Facts & Figures by Country
    • 3.6.1 Latin America Frovatriptan Sales by Country
    • 3.6.2 Latin America Frovatriptan Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Frovatriptan Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Frovatriptan Sales by Country
    • 3.7.2 Middle East and Africa Frovatriptan Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Frovatriptan Historic Market Analysis by Type

  • 4.1 Global Frovatriptan Sales Market Share by Type (2016-2021)
  • 4.2 Global Frovatriptan Revenue Market Share by Type (2016-2021)
  • 4.3 Global Frovatriptan Price by Type (2016-2021)

5 Global Frovatriptan Historic Market Analysis by Application

  • 5.1 Global Frovatriptan Sales Market Share by Application (2016-2021)
  • 5.2 Global Frovatriptan Revenue Market Share by Application (2016-2021)
  • 5.3 Global Frovatriptan Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Ligand Pharmaceuticals
    • 6.1.1 Ligand Pharmaceuticals Corporation Information
    • 6.1.2 Ligand Pharmaceuticals Description and Business Overview
    • 6.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Ligand Pharmaceuticals Product Portfolio
    • 6.1.5 Ligand Pharmaceuticals Recent Developments/Updates
  • 6.2 Endo Pharmaceuticals
    • 6.2.1 Endo Pharmaceuticals Corporation Information
    • 6.2.2 Endo Pharmaceuticals Description and Business Overview
    • 6.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Endo Pharmaceuticals Product Portfolio
    • 6.2.5 Endo Pharmaceuticals Recent Developments/Updates
  • 6.3 Doc Generici
    • 6.3.1 Doc Generici Corporation Information
    • 6.3.2 Doc Generici Description and Business Overview
    • 6.3.3 Doc Generici Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Doc Generici Product Portfolio
    • 6.3.5 Doc Generici Recent Developments/Updates
  • 6.4 Menarini
    • 6.4.1 Menarini Corporation Information
    • 6.4.2 Menarini Description and Business Overview
    • 6.4.3 Menarini Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Menarini Product Portfolio
    • 6.4.5 Menarini Recent Developments/Updates
  • 6.5 Novartis
    • 6.5.1 Novartis Corporation Information
    • 6.5.2 Novartis Description and Business Overview
    • 6.5.3 Novartis Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Novartis Product Portfolio
    • 6.5.5 Novartis Recent Developments/Updates
  • 6.6 Almac
    • 6.6.1 Almac Corporation Information
    • 6.6.2 Almac Description and Business Overview
    • 6.6.3 Almac Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Almac Product Portfolio
    • 6.6.5 Almac Recent Developments/Updates
  • 6.7 Glenmark Generics
    • 6.6.1 Glenmark Generics Corporation Information
    • 6.6.2 Glenmark Generics Description and Business Overview
    • 6.6.3 Glenmark Generics Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Glenmark Generics Product Portfolio
    • 6.7.5 Glenmark Generics Recent Developments/Updates
  • 6.8 Teva
    • 6.8.1 Teva Corporation Information
    • 6.8.2 Teva Description and Business Overview
    • 6.8.3 Teva Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Teva Product Portfolio
    • 6.8.5 Teva Recent Developments/Updates
  • 6.9 Zambon
    • 6.9.1 Zambon Corporation Information
    • 6.9.2 Zambon Description and Business Overview
    • 6.9.3 Zambon Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Zambon Product Portfolio
    • 6.9.5 Zambon Recent Developments/Updates
  • 6.10 Apotex
    • 6.10.1 Apotex Corporation Information
    • 6.10.2 Apotex Description and Business Overview
    • 6.10.3 Apotex Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Apotex Product Portfolio
    • 6.10.5 Apotex Recent Developments/Updates
  • 6.11 G.L. Pharma
    • 6.11.1 G.L. Pharma Corporation Information
    • 6.11.2 G.L. Pharma Frovatriptan Description and Business Overview
    • 6.11.3 G.L. Pharma Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 G.L. Pharma Product Portfolio
    • 6.11.5 G.L. Pharma Recent Developments/Updates
  • 6.12 Chanelle Pharma
    • 6.12.1 Chanelle Pharma Corporation Information
    • 6.12.2 Chanelle Pharma Frovatriptan Description and Business Overview
    • 6.12.3 Chanelle Pharma Frovatriptan Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Chanelle Pharma Product Portfolio
    • 6.12.5 Chanelle Pharma Recent Developments/Updates

7 Frovatriptan Manufacturing Cost Analysis

  • 7.1 Frovatriptan Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Frovatriptan
  • 7.4 Frovatriptan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Frovatriptan Distributors List
  • 8.3 Frovatriptan Customers

9 Frovatriptan Market Dynamics

  • 9.1 Frovatriptan Industry Trends
  • 9.2 Frovatriptan Growth Drivers
  • 9.3 Frovatriptan Market Challenges
  • 9.4 Frovatriptan Market Restraints

10 Global Market Forecast

  • 10.1 Frovatriptan Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Frovatriptan by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Frovatriptan by Type (2022-2027)
  • 10.2 Frovatriptan Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Frovatriptan by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Frovatriptan by Application (2022-2027)
  • 10.3 Frovatriptan Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Frovatriptan by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Frovatriptan by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Hospital
    Drug Store

    Segment by Application
    Menstrual Migraines
    Migraine with Aura
    Migraine without Aura

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Ligand Pharmaceuticals
    Endo Pharmaceuticals
    Doc Generici
    Menarini
    Novartis
    Almac
    Glenmark Generics
    Teva
    Zambon
    Apotex
    G.L. Pharma
    Chanelle Pharma


    Summary:
    Get latest Market Research Reports on Frovatriptan. Industry analysis & Market Report on Frovatriptan is a syndicated market report, published as Global Frovatriptan Market Research Report 2021. It is complete Research Study and Industry Analysis of Frovatriptan market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,103.08
    3,154.62
    4,206.16
    2,420.57
    3,630.85
    4,841.13
    315,514.20
    473,271.30
    631,028.40
    217,455.34
    326,183.01
    434,910.68
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report